![](/img/cover-not-exists.png)
GREATER LIKELIHOOD OF REGRESSION OF CORONARY ATHEROSCLEROSIS WITH THE PCSK9 INHIBITOR, EVOLOCUMAB, IN PATIENTS WITH HIGHER LP(A) LEVELS
Scherer, Daniel, Puri, Rishi, Ballantyne, Christie, Cho, Leslie, Brennan, Danielle, Kassahun, Helina, Somaratne, Ransi, Wasserman, Scott, Nissen, Steven, Nicholls, StephenVolume:
71
Language:
english
Journal:
Journal of the American College of Cardiology
DOI:
10.1016/S0735-1097(18)30558-8
Date:
March, 2018
File:
PDF, 147 KB
english, 2018